Agilent Technologies reported better-than-expected third-quarter earnings and issued upbeat fourth-quarter guidance, indicating a potential improvement in market conditions. Revenue declined slightly year-over-year but surpassed analyst estimates, driven by strong performance in its Life Sciences and Applied Markets segment. The company also raised its full-year revenue and earnings outlook, reflecting a positive outlook for the future. Analysts have responded positively to the results, with several raising their price targets on Agilent stock.
